STAT1 single nucleotide polymorphisms and susceptibility to immune thrombocytopenia

Autoimmunity

Volumn 48, Issue 5, 2015, Pages 305-312

  Chen, Zhenping ^a,b   Guo, Zhenxing ^c   Ma, Jingyao ^a,b   Liu, Fuhong ^a,b   Gao, Chao ^a,b   Liu, Shuguang ^a,b   Wang, Ami ^d   Wu, Runhui ^a,b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c FIRST HOSPITAL OF TSINGHUA UNIVERSITY   (China)

^d QUEEN S UNIVERSITY   (Canada)

Author keywords

Children; IFN g; Immune thrombocytopenia; Single nucleotide polymorphism; STAT1

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4; MESSENGER RNA; STAT1 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; AUTOANTIBODY; CYTOKINE;

ADOLESCENT; ARTICLE; AUTOIMMUNITY; CHILD; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE MAP; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INFANT; MAJOR CLINICAL STUDY; MALE; PROMOTER REGION; PROSPECTIVE STUDY; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; TH1 CELL; TH1 TH2 BALANCE; TH2 CELL; THROMBOCYTE COUNT; ALLELE; BLOOD; CASE CONTROL STUDY; CD4 LYMPHOCYTE COUNT; GENE EXPRESSION; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; NEWBORN; PRESCHOOL CHILD; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;

ADOLESCENT; ALLELES; AUTOANTIBODIES; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; CYTOKINES; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PLATELET COUNT; POLYMORPHISM, SINGLE NUCLEOTIDE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RNA, MESSENGER; STAT1 TRANSCRIPTION FACTOR; TH1 CELLS; TH2 CELLS;

EID: 84942802240     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2015.1016218     Document Type: Article

References (32)

1. McMillan, R. 2000. The pathogenesis of chronic immune (idiopathic) thrombocytopenic purpura. Semin. Hematol. 37: 5-9.
2. Zhou, B., H. Zhao, R. C. Yang, and Z. C. Han. 2005. Multidysfunctional pathophysiology in ITP. Crit. Rev. Oncol. Hematol. 54: 107-116.
3. Shan, N. N., Y. Hu, M. Hou, et al. 2014. Decreased Tim-3 and its correlation with Th1 cells in patients with immune thrombocytopenia. Thromb. Res. 133: 52-56.
4. Li, H., H. Zhao, F. Xue, et al. 2013. Reduced expression of MIR409-3p in primary immune thrombocytopenia. Br. J. Haematol. 161: 128-135.
5. Shao, Q., H. Ning, J. Lv, et al. 2012. Regulation of Th1/Th2 polarization by tissue inhibitor of metalloproteinase-3 via modulating dendritic cells. Blood. 119: 4636-4644.
6. Stasi, R., G. Del Poeta, E. Stipa, et al. 2007. Response to B-cell depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura. Blood. 110: 2924-2930.
7. Yang, Q., B. Wang, H. Yu, et al. 2011. TLR7 promotes Th1 polarization in immune thrombocytopenia. Thromb. Res. 128: 237-242.
8. Zhong, H., W. Bao, X. Li, et al. 2012. CD16+ monocytes control Tcell subset development in immune thrombocytopenia. Blood. 120: 3326-3335.
9. Kuter, DJ. 2013. The biology of thrombopoietin and thrombopoietin receptor agonists. Int. J. Hematol. 98: 10-23.
10. Horvath, CM. 2004. The Jak-STAT pathway stimulated by interferon gamma. Sci. STKE. 2004: tr8.
11. Shuai, K., and B. Liu. 2003. Regulation of JAK-STAT signalling in the immune system. Nat. Rev. Immunol. 3: 900-911.
12. Dong, J., Q. X. Wang, C. Y. Zhou, et al. 2007. Activation of the STAT1 signalling pathway in lupus nephritis in MRL/lpr mice. Lupus. 16: 101-109.
13. Kawasaki, M., M. Fujishiro, A. Yamaguchi, et al. 2011. Possible role of the JAK/STAT pathways in the regulation of T cellinterferon related genes in systemic lupus erythematosus. Lupus. 20: 1231-1239.
14. Kyogoku, C., B. Smiljanovic, J. R. Grun, et al. 2013. Cell-specific type I IFN signatures in autoimmunity and viral infection: what makes the difference? PLoS One. 8: e83776.
15. Gliozzi, M., T. Greenwell-Wild, W. Jin, et al. 2013. A link between interferon and augmented plasmin generation in exocrine gland damage in Sjogren's syndrome. J. Autoimmun. 40: 122-133.
16. Hahn, W. H., J. S. Suh, S. H. Cho, et al. 2010. Polymorphisms of signal transducers and activators of transcription 1 and 4 (STAT1 and STAT4) contribute to progression of childhood IgA nephropathy. Cytokine. 50: 69-74.
17. Diogo, D., Y. Okada, and R. M. Plenge. 2014. Genome-wide association studies to advance our understanding of critical cell types and pathways in rheumatoid arthritis: recent findings and challenges. Curr. Opin. Rheumatol. 26: 85-92.
18. Butterbach, K., L. Beckmann, S. de Sanjose, et al. 2011. Association of JAK-STAT pathway related genes with lymphoma risk: results of a European case-control study (EpiLymph). Br. J. Haematol. 153: 318-333.
19. Provan, D., R. Stasi, A. C. Newland, et al. 2010. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 115: 168-186.
20. Barrett, J. C., B. Fry, J. Maller, and M. J. Daly. 2005. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 21: 263-265.
21. Seddighzadeh, M., A. Gonzalez, B. Ding, et al. 2012. Variants within STAT genes reveal association with anticitrullinated protein antibody-negative rheumatoid arthritis in 2 European populations. J. Rheumatol. 39: 1509-1516.
22. Zhou, Z., Z. Chen, H. Li, et al. 2008. BAFF and BAFF-R of peripheral blood and spleen mononuclear cells in idiopathic thrombocytopenic purpura. Autoimmunity. 1: 12-19.
23. Talaat, R. M., A. M. Elmaghraby, S. S. Barakat, and M. E. Ebeed. 2014. Alterations in immune cell subsets and their cytokine secretion profile in childhood Idiopathic Thrombocytopenic Purpura (ITP). Clin. Exp. Immunol. 176: 291-300.
24. Wang, T., H. Zhao, H. Ren, et al. 2005. Type 1 and type 2 T-cell profiles in idiopathic thrombocytopenic purpura. Haematologica. 90: 914-923.
25. Mouzaki, A., M. Theodoropoulou, I. Gianakopoulos, et al. 2002. Expression patterns of Th1 and Th2 cytokine genes in childhood idiopathic thrombocytopenic purpura (ITP) at presentation and their modulation by intravenous immunoglobulin G (IVIg) treatment: their role in prognosis. Blood. 100: 1774-1779.
26. Begitt, A., M. Droescher, K. P. Knobeloch, and U. Vinkemeier. 2011. SUMO conjugation of STAT1 protects cells from hyperresponsiveness to IFNgamma. Blood. 118: 1002-1007.
27. Hu, X., W. P. Li, C. Meng, and L. B. Ivashkiv. 2003. Inhibition of IFN-gamma signaling by glucocorticoids. J. Immunol. 170: 4833-4839.
28. Yacobovich, J., S. Revel-Vilk, and H. Tamary. 2013. Childhood immune thrombocytopenia-who will spontaneously recover? Semin. Hematol. 50: S71-S74.
29. Zhang, B., C. Lo, L. Shen, et al. 2011. The role of vanin-1 and oxidative stress-related pathways in distinguishing acute and chronic pediatric ITP. Blood. 117: 4569-4579.
30. Bauer-Mehren, A., L. I. Furlong, M. Rautschka, and F. Sanz. 2009. From SNPs to pathways: integration of functional effect of sequence variations on models of cell signalling pathways. BMC Bioinformatics. 10: S6.
31. Namjou, B., A. L. Sestak, D. L. Armstrong, et al. 2009. Highdensity genotyping of STAT4 reveals multiple haplotypic associations with systemic lupus erythematosus in different racial groups. Arthritis Rheum. 60: 1085-1095.
32. Kawasaki, A., I. Ito, K. Hikami, et al. 2008. Role of STAT4 polymorphisms in systemic lupus erythematosus in a Japanese population: a case-control association study of the STAT1-STAT4 region. Arthritis Res. Ther. 10: R113.